VREX (Varex Imaging Corp) — AI Stock Analysis & Recommendation
Research of October 15, 2026 · Healthcare / Electronic Components, NEC
TradeFlare's AI research teams rate VREX a HOLD. The latest price is $18.45.
The research plan
- Entry: $18.39
- Target: $21.15
- Stop: $15.63
- Time horizon: days
The pending acquisition creates significant short-term uncertainty, making a longer time horizon speculative.
Why
The pending acquisition creates significant short-term uncertainty, making a longer time horizon speculative. Catalysts to watch: Successful completion of the Teledyne Technologies acquisition at the proposed price; Positive news or analyst upgrades that counter the recent price target cut; A significant volume-driven breakout above the acquisition price, indicating strong independent momentum. Key risks: The acquisition deal may fall through or be renegotiated at a lower price, leading to a sharp price decline; Continued operational challenges and supply chain disruptions could negatively impact Varex's standalone performance if the deal falters; Analyst price target cuts and a lack of sustained institutional interest despite the 52-week high.
What could push VREX higher
- Successful completion of the Teledyne Technologies acquisition at the proposed price.
- Positive news or analyst upgrades that counter the recent price target cut.
- A significant volume-driven breakout above the acquisition price, indicating strong independent momentum.
Key risks for VREX
- The acquisition deal may fall through or be renegotiated at a lower price, leading to a sharp price decline.
- Continued operational challenges and supply chain disruptions could negatively impact Varex's standalone performance if the deal falters.
- Analyst price target cuts and a lack of sustained institutional interest despite the 52-week high.
What each AI research team found
Fundamental team: Neutral · valuation: fair
Varex Imaging is currently fairly valued, with its stock price largely capped by a pending acquisition. While the company holds a strong market position and exhibits steady revenue growth, recent profitability concerns and inconsistent free cash flow generation temper its outlook. The acquisition price by Teledyne serves as a near-term target and a de facto valuation floor.
- Varex Imaging is the world's largest independent manufacturer of X-ray imaging components, serving both medical and industrial sectors.
- A pending acquisition by Teledyne Technologies at $18.90 per share largely dictates the current stock price and limits short-term upside potential.
- While revenue shows steady growth (3.7% YoY), profitability has been challenged with negative net income in FY2025 and volatile free cash flow.
Technical team: Bullish
The strong uptrend and bullish pattern formation provide a bullish bias, suggesting potential for a breakout. However, concerns regarding subdued volume and neutral-to-bearish momentum indicators warrant caution, leading to a moderate conviction.
- The price is in a strong uptrend, trading above key moving averages which are also trending upwards and diverging, suggesting further upside potential towards the next resistance level.
- The chart shows a significant volume spike on 2026-08-25 with a price increase, but subsequent volume has been below average, leading to a neutral outlook with no clear entry or exit points.
- Momentum indicators suggest a neutral to slightly bearish outlook with sideways price action, lacking clear trading signals.
Sentiment team: Neutral
Varex Imaging (VREX) presents a neutral sentiment across news, social media, and analyst coverage, reflecting a balance of positive developments like earnings beats and acquisition news against concerns such as price target cuts and shareholder investigations. The stock is near its 52-week high, indicating potential momentum, but mixed analyst views and insider selling temper immediate bullish conviction.
- Varex Imaging (VREX) exhibits a neutral overall news sentiment, characterized by a balanced mix of bullish headlines related to earnings beats and acquisition news, alongside bearish sentiment stemming from price target cuts and shareholder fairness...
- Varex Imaging (VREX) exhibits a neutral sentiment driven by a mixed bag of news, including a positive earnings surprise and analyst 'Hold' ratings, offset by limited social media buzz, increased short interest, and a price target cut. (Score: 0)
- Varex Imaging (VREX) exhibits a neutral sentiment driven by a mix of positive news regarding potential buyouts and earnings beats, countered by analyst downgrades and a price target cut, alongside net insider selling. (Consensus: Mixed, leaning Hold)
Risk team: High
VREX presents a high-risk profile due to extreme historical volatility, a significant past drawdown, and substantial uncertainty surrounding its pending acquisition. The combination of these factors, along with operational risks and a moderate probability of bankruptcy, necessitates a cautious approach and a small position size.
- Deep Drawdown and High Volatility: VREX has experienced a significant -71.14% drawdown over the past year and exhibits exceptionally high 60-day annualized volatility of 100.88%, indicating substantial downside risk and price uncertainty.
- Acquisition Uncertainty: The pending acquisition by Teledyne Technologies introduces significant uncertainty regarding deal terms, regulatory approval, and the future strategic direction of VREX.
- Operational and Supply Chain Disruptions: The company faces ongoing risks from supply chain challenges, component shortages, rising manufacturing costs, and potential delivery delays, which can impact financial performance.
VREX at a glance
| Market value | $775.1M |
| Price / earnings | 34.1 |
| Revenue growth (year over year) | 5.3% |
| Profit margin | 2.6% |
| Debt / equity | 0.70 |
Every AI call on VREX since August 13, 2026, and what happened next (7 calls) →
Frequently asked questions
Is VREX a buy? In its research of October 15, 2026, TradeFlare's AI rated VREX a HOLD. This is AI-generated research, not financial advice.
What is the price target for VREX? The research sets a target of $21.15 with a stop at $15.63.
When was this analysis last updated? October 15, 2026. Stocks on TradeFlare's lists are re-researched every market night. How the research works.
Research of October 15, 2026 · AI-generated analysis for educational purposes, can be wrong, not financial advice.